Trial NCT04224688

View at ClinicalTrials.gov 
Org. Study IDs: TP0006
Secondary IDs: 2019-003451-11

Last trial update was posted on 2023-08-08

MeSH Interventions

Rozanolixizumab

MeSH Conditions

Purpura, Thrombocytopenic, Idiopathic Thrombocytopenia

Other Conditions

Primary Immune Thrombocytopenia

Stopping Reasons

Strategic Business Decision; Not a safety decision

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID